SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 115 filers reported holding SANA BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $149 | -34.4% | 38,482 | +1.2% | 0.00% | – |
Q2 2023 | $227 | +73.3% | 38,039 | -5.1% | 0.00% | – |
Q1 2023 | $131 | -45.9% | 40,078 | -34.7% | 0.00% | – |
Q4 2022 | $242 | -99.9% | 61,378 | -0.1% | 0.00% | -100.0% |
Q3 2022 | $369,000 | -6.3% | 61,464 | +0.3% | 0.00% | 0.0% |
Q2 2022 | $394,000 | -22.3% | 61,269 | -0.1% | 0.00% | 0.0% |
Q1 2022 | $507,000 | -46.6% | 61,322 | -0.0% | 0.00% | 0.0% |
Q4 2021 | $949,000 | -23.1% | 61,323 | +11.9% | 0.00% | 0.0% |
Q3 2021 | $1,234,000 | +171.8% | 54,792 | +137.2% | 0.00% | – |
Q2 2021 | $454,000 | -55.4% | 23,100 | -24.0% | 0.00% | -100.0% |
Q1 2021 | $1,017,000 | – | 30,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 34,239,018 | $220,158,000 | 8.29% |
Crestline Management, LP | 3,365,624 | $21,641,000 | 2.82% |
Omega Fund Management, LLC | 843,750 | $5,425,000 | 1.73% |
Alphabet Inc. | 2,812,500 | $18,084,000 | 0.98% |
HARVARD MANAGEMENT CO INC | 468,749 | $3,014,000 | 0.35% |
PUBLIC SECTOR PENSION INVESTMENT BOARD | 6,400,000 | $41,152,000 | 0.35% |
PFM Health Sciences, LP | 952,733 | $6,126,000 | 0.23% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 156,254 | $1,005,000 | 0.20% |
Viewpoint Capital Management LLC | 23,545 | $151,000 | 0.14% |
Artal Group S.A. | 400,000 | $2,572,000 | 0.14% |